Bayer AG - Stockholders' Newsletter Second Quarter 2007 - Bayer Group Consolidated Balance Sheets

2 of 8

Financial Statements

Bayer Group Consolidated Balance Sheets

	June 30, 2006	June 30, 2007	Dec. 31, 2006
€ million
Noncurrent assets
Goodwill	7,753	8,439	8,227
Other intangible assets	15,922	15,112	15,807
Property, plant and equipment	9,208	8,662	8,867
Investments in associates	760	501	532
Other financial assets	1,528	1,190	1,094
Other receivables	261	413	176
Deferred taxes	982	773	1,205
	36,414	35,090	35,908
Current assets
Inventories	7,044	6,277	6,153
Trade accounts receivable	6,638	6,843	5,802
Other financial assets	445	252	401
Other receivables	1,530	1,637	1,567
Claims for income tax refunds	232	243	220
Cash and cash equivalents	2,491	2,980	2,915
Assets held for sale and discontinued operations	1,396	82	2,925
	19,776	18,314	19,983

Total assets	56,190	53,404	55,891

Stockholders’ equity
Capital stock of Bayer AG	1,870	1,957	1,957
Capital reserves of Bayer AG	2,942	4,028	4,028
Other reserves	6,865	10,183	6,782
	11,677	16,168	12,767
Equity attributable to minority interest	1,150	81	84
	12,827	16,249	12,851

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	6,237	5,550	6,543
Other provisions	1,771	1,671	1,464
Financial liabilities	10,373	13,644	14,723
Other liabilities	517	504	449
Deferred taxes	4,240	4,347	4,346
	23,138	25,716	27,525
Current liabilities
Other provisions	3,803	4,087	3,765
Financial liabilities	12,053	2,309	5,078
Trade accounts payable	1,995	2,244	2,369
Income tax liabilities	116	127	109
Other liabilities	1,822	2,672	3,346
Liabilities directly related to assets held for sale and discontinued operations	436	-	848
	20,225	11,439	15,515

Total stockholders’ equity and liabilities	56,190	53,404	55,891